Psychedelic Commons
ExploreMethodsAbout
Share your data

Mathew SJ

Department of Psychiatry and Behavioral Sciences, Naresh K. Vashisht College of Medicine, Texas A&M University, Bryan, USA.

4 papers · ORCID

View
ArticleKetamine

Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

Gould TD, Mathew SJ, Fava M +1

Europe PMC2026
View
ArticleKetamine

High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression?

Shah K, Herzog R, Swann AC +4

Europe PMC2026
View
ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025
View
ArticlePsilocybin

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.

Jha MK, Mathew SJ

Europe PMC2023
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.